Phathom Pharmaceuticals
PHAT
PHAT
133 hedge funds and large institutions have $1.31B invested in Phathom Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
17% more funds holding
Funds holding: 114 → 133 (+19)
7.1% more ownership
Funds ownership: 99.27% → 106.36% (+7.1%)
Holders
133
Holding in Top 10
12
Calls
$4.5M
Puts
$1.05M
Top Buyers
| 1 | +$56.2M | |
| 2 | +$32.3M | |
| 3 | +$26.2M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$25.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.5M |
Top Sellers
| 1 | -$16M | |
| 2 | -$7.05M | |
| 3 | -$5.84M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$4.07M |
| 5 |
Two Sigma Investments
New York
|
-$2.7M |